Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cancer J Sci Am ; 3 Suppl 1: S16-21, 1997 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-9457388

RESUMO

PURPOSE: This article investigates the safety and efficacy of a simple cisplatin-based biochemotherapy regimen, containing single-agent cisplatin plus recombinant interleukin-2 (rIL-2) and recombinant interferon-alpha (rIFN-alpha), in the treatment of metastatic melanoma. PATIENTS AND METHODS: Between December 1990 and April 1997, 129 patients were treated with cisplatin (100 mg/m2, day 0) plus continuous intravenous infusion rIL-2 (18 MIU/m2/day, days 3-6 and days 17-21) and subcutaneous rIFN-alpha (9 MIU three times per week) plus or minus tamoxifen (160 mg/day) on three different protocols. Tumor response, disease-free survival, and overall survival were evaluated for all evaluable patients (N = 127). RESULTS: The overall response rate was 49%, and 10% of patients achieved a complete response. Responses were observed at all sites of metastases. In one case, a patient with a large cutaneous inguinal mass experienced a dramatic regression of that lesion within 1 month. The median disease-free survival was 5 months, and median overall survival was 11 months. Patients who responded had a significant survival advantage over nonresponders, and patients who achieved a complete response had a significant survival advantage over patients with a partial response. Toxicities were manageable and reversible upon discontinuation of therapy. CONCLUSION: The response rates achieved with this simple biochemotherapy regimen are comparable to those for other cisplatin-based biochemotherapy regimens, which use more complex multiagent chemotherapy regimens. We found no added clinical benefit from the addition of tamoxifen to cisplatin.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Imunoterapia , Interleucina-2/administração & dosagem , Melanoma/terapia , Adolescente , Adulto , Idoso , Cisplatino/administração & dosagem , Terapia Combinada , Feminino , Humanos , Injeções Subcutâneas , Interferon alfa-2 , Interferon-alfa/administração & dosagem , Masculino , Melanoma/mortalidade , Pessoa de Meia-Idade , Proteínas Recombinantes/administração & dosagem , Taxa de Sobrevida , Tamoxifeno/administração & dosagem , Resultado do Tratamento
2.
Biochim Biophys Acta ; 1216(1): 31-42, 1993 Oct 19.
Artigo em Inglês | MEDLINE | ID: mdl-8218413

RESUMO

We have studied the distribution of the protein synthesis inhibitory activity in the tissues of Saponaria officinalis L. (Caryophyllaceae). Seven major saporins, ribosome-inactivating proteins, were purified to apparent homogeneity from leaves, roots and seeds using a new procedure of RIPs isolation including ion-exchange and hydrophobic chromatography. They all catalysed the depurination of rat liver ribosomes, which generate the Endo's diagnostic rRNA fragment upon treatment with acid aniline, thus indicating that A4324 from the 28S rRNA has been released (Endo et al. (1987) J. Biol. Chem. 262, 5908-5912). The molecular mass of saporins by SDS-PAGE ranged between 30.2 and 31.6 kDa and by gel-filtration between 27.5 and 30.1 kDa. Amino acid composition and amino-terminal amino acid sequence indicate that all saporins may be considered isoforms. Only two saporins present in roots were glycosylated (SO-R1 and SO-R3). All saporins are very active on cell-free translation systems derived from rabbit reticulocyte lysates, rat liver, Triticum aestivum L., Cucumis sativus L. and Vicia sativa L. However, they are poor inhibitors of an Escherichia coli translation system. They inhibit protein synthesis in HeLa, BeWo and NB 100 cells, HeLa cells being the most resistant. The enzymatic activity of at least one saporin isoform was dependent on magnesium concentration in the standard rat liver cell-free system.


Assuntos
Imunotoxinas , N-Glicosil Hidrolases/isolamento & purificação , Proteínas de Plantas/isolamento & purificação , Ribossomos/metabolismo , Sequência de Aminoácidos , Aminoácidos/análise , Compostos de Anilina , Animais , Linhagem Celular , Sistema Livre de Células/efeitos dos fármacos , Escherichia coli , Humanos , Dados de Sequência Molecular , N-Glicosil Hidrolases/química , Proteínas de Plantas/química , Proteínas de Plantas/farmacologia , Biossíntese de Proteínas/efeitos dos fármacos , Coelhos , Ratos , Proteínas Inativadoras de Ribossomos , Proteínas Inativadoras de Ribossomos Tipo 1 , Ribossomos/efeitos dos fármacos , Saporinas
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...